2018
DOI: 10.1111/ijpp.12436
|View full text |Cite
|
Sign up to set email alerts
|

Unlicensed medicines use: a UK guideline analysis using AGREE II†

Abstract: ObjectivesThere is widespread use of unlicensed medicines within primary and secondary care but little information is available around how these medicines are used. This analysis examines and evaluates the content and quality of relevant guidance documentation currently in use within the UK.MethodsGuidance documents were identified through a literature search as well as email requests to pharmacy organisations throughout the UK. Unlicensed medicine documentation suitable for inclusion in the analysis underwent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
10
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(10 citation statements)
references
References 16 publications
0
10
0
Order By: Relevance
“…There is often an expectation for community services to take responsibility for the prescribing and supply of the unlicensed drug thereafter. A survey of community pharmacists highlighted a lack of consistent communication concerning patients between hospital and community settings 11. Hospital healthcare professionals do not always provide enough information to parents, carers, family doctors and community pharmacists about the new medicines prescribed or provide it in a timely fashion 11.…”
Section: Problems That May Arisementioning
confidence: 99%
See 1 more Smart Citation
“…There is often an expectation for community services to take responsibility for the prescribing and supply of the unlicensed drug thereafter. A survey of community pharmacists highlighted a lack of consistent communication concerning patients between hospital and community settings 11. Hospital healthcare professionals do not always provide enough information to parents, carers, family doctors and community pharmacists about the new medicines prescribed or provide it in a timely fashion 11.…”
Section: Problems That May Arisementioning
confidence: 99%
“…A survey of community pharmacists highlighted a lack of consistent communication concerning patients between hospital and community settings 11. Hospital healthcare professionals do not always provide enough information to parents, carers, family doctors and community pharmacists about the new medicines prescribed or provide it in a timely fashion 11. This lack of communication leads to family doctors and community pharmacists not being well informed about the new drug, doctors refusing to prescribe and/or community pharmacists being unable to source and so delaying supply with overall disrupted treatment for patients 12…”
Section: Problems That May Arisementioning
confidence: 99%
“…The majority of medicines prescribed to adults are licensed products with clearly defined usage and will have undergone rigorous regulatory procedures to evidence drug efficacy, safety, administration, indications and shelf-life. However, the use of unlicensed, off-label, and personalized medication is also common, especially within certain patient demographics such as neonates and the elderly [1]. It has been stated that 93% of neonates in intensive care will receive at least one unlicensed or off-label medicine [2].…”
Section: Introductionmentioning
confidence: 99%
“…It has been stated that 93% of neonates in intensive care will receive at least one unlicensed or off-label medicine [2]. Specials medications are formulations which are bespoke manufactured for patients with unique prescription requirements, specifically for individuals who clinically require something that is different from the standard licensed format [1]. This may be because: they are a baby/small child or elderly and require a different strength or format, they are allergic to ingredients, have swallowing difficulties [3], or other complexities; the drug is new and / or there is not enough demand; or because there are supply issues with a licensed product [4].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation